Skincare brand Be Clinical on Monday said it has raised ₹21 crore in a seed funding round, led by venture capital fund Sauce, to support product innovation and expand its clinical skincare portfolio.The funding round also saw participation from V3 Ventures (Verlinvest SA) and a group of angel investors, including Mokobara founders Sangeet Agrawal and Navin Parwal; SVP & Managing Director for Greater China & North Asia at Reckitt, Arjun Purkayastha; and Shaunak Chirayu Amin, the company said in a statement.The company plans to utilise the fresh capital to strengthen its research and development (R&D) capabilities, expand the clinical skincare range, scale manufacturing capacity and support expansion into new markets and geographies."For me, the ₹21 crore we have raised is less about the capital, and more about the responsibility that comes with that belief. It gives us the ability to invest deeper in R&D, strengthen our manufacturing and clinical capabilities, build a stronger team, and take Be Clinical to more consumers across India,” Hemangi Dhir, Founder, Be Clinical, said.Published on August 24, 2026